Product NDC: | 57664-506 |
Proprietary Name: | Metoprolol Tartrate |
Non Proprietary Name: | Metoprolol tartrate |
Active Ingredient(s): | 25 mg/1 & nbsp; Metoprolol tartrate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 57664-506 |
Labeler Name: | Caraco Pharmaceutical Laboratories, Ltd. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076670 |
Marketing Category: | ANDA |
Start Marketing Date: | 20040115 |
Package NDC: | 57664-506-58 |
Package Description: | 1000 TABLET in 1 BOTTLE (57664-506-58) |
NDC Code | 57664-506-58 |
Proprietary Name | Metoprolol Tartrate |
Package Description | 1000 TABLET in 1 BOTTLE (57664-506-58) |
Product NDC | 57664-506 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Metoprolol tartrate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20040115 |
Marketing Category Name | ANDA |
Labeler Name | Caraco Pharmaceutical Laboratories, Ltd. |
Substance Name | METOPROLOL TARTRATE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |